Figure 2 - uploaded by Bontha Babu
Content may be subject to copyright.
Scheme of population-level screening of sickle cell disease (SCD) in tribal communities of India.

Scheme of population-level screening of sickle cell disease (SCD) in tribal communities of India.

Source publication
Article
Full-text available
Objective To describe the development and implementation of a population-based screening programme for sickle cell disease (SCD) implemented in 12 SCD-endemic and tribal-dominated primary/community health centres (PHCs/CHCs) across six districts of India. Setting India reports a huge burden of SCD, especially among indigenous (tribal) communities....

Context in source publication

Context 1
... this context, the extended family is an extension of a nuclear family to include other relatives such as parents, grandparents, siblings, aunts, uncles, cousins, nieces and nephews of the couple. The screening was carried out in three tiers to cover a maximum number of people ( Figure 2). In the absence of a state-led screening programme, it was expected that there would be people (both children and adults) living with SCD without being aware of their condition. ...

Similar publications

Article
Full-text available
Sickle-cell disease (SCD) a hereditary autosomal recessive disorder is the most common haemoglobinopathy worldwide. In India, it is the second most common haemoglobinopathy next to Thalassemia, prevalent in the tribal population of Central and Southern parts of India. The pathophysiology of the disease is point mutation in the beta globin chain lea...
Article
Full-text available
We report a large series of 40 patients presenting EPAS1‐mutated paraganglioma (PGL) in whom we investigated a cause underlying chronic hypoxia. Four patients suffered from hypoxaemic heart disease. In patients with available haemoglobin electrophoresis results, 59% presented with a haemoglobin disorder, including six with sickle cell disease, five...
Article
Full-text available
Sickle cell anaemia is a haemoglobinopathy with an autosomal recessive inheritance. With the advent of advanced medical care, longevity of patients with sickle-cell disease has improved greatly. Our aim is to highlight the perioperative strategies to avoid complications due to the disease itself which can get exacerbated by moderate-high risk surge...
Article
Full-text available
Background: Sickle cell disease (SCD) is the most common form of an inherited haemoglobinopathy, accounting for about 70% of the world’s major haemoglobinopathies, and the greatest burden is in sub-Saharan Africa. Fetal haemoglobin (HbF) delays the polymerization of Sickle cell disease. In Nigeria, there is no recent data on the levels of haemoglob...
Article
Full-text available
Hemoglobinopathies, including Thalassemia and sickle-cell syndromes are lifelong diseases with a significant impact on patients, families, and healthcare resources. Despite therapeutic progress, Pakistan, located within the Thalassemia belt, lacks comprehensive data on the epidemiology, clinical course, mortality, complications, and treatment outco...

Citations

... Precautions have been taken to prevent program duplication and counterproductivity. These districts' demographic and SCD-related information is provided elsewhere [15,16]. ...
... The capacity of the primary health care system and the SCD-related awareness of the community for carrying out the intervention program were examined. Findings of the formative phase were reported [16,[18][19][20][21]. Based on the findings of the formative research, an intervention with an inclusive partnership strategy was developed and implemented. ...
... They were trained in different steps of electrophoresis, including buffer preparation, preparation, and application of hemolysate on cellulose acetate strips of 17 cm, etc. The details of the screening model developed under this study were given elsewhere [16]. These healthcare staff were trained for hands-on experience to build competency and sustain motivation. ...
Article
Sickle cell disease (SCD) affects 5% of the global population, with over 300,000 infants born yearly. In India, 73% of those with the sickle hemoglobin gene belong to indigenous tribes in remote regions lacking proper healthcare. Despite the prevalence of SCD, India lacked state-led public health programs until recently, leaving a gap in screening and comprehensive care. Hence, the Indian Council of Medical Research conducted implementation research to address this gap. This paper discusses the development and impact of the program, including screening and treatment coverage for SCD in tribal areas. With a quasi-experimental design, this study was conducted in six tribal-dominated districts in three phases - formative, intervention, and evaluation. The intervention included advocacy, partnership building, building the health system's capacity and community mobilization, and enabling the health systems to screen and manage SCD patients. The capacity building included improving healthcare workers' skills through training and infrastructure development of primary healthcare (PHC) facilities. The impact of the intervention is visible in terms of people's participation (54%, 76% and 93% of the participants participated in some intervention activities, underwent symptomatic screening and demanded the continuity of the program, respectively), and improvement in SCD-related knowledge of the community and health workers (with more than 50% of net change in many of the knowledge-related outcomes). By developing screening and treatment models, this intervention model demonstrated the feasibility of SCD care at the PHC level in remote rural areas. This accessible approach allows the tribal population in India to routinely seek SCD care at their local PHCs, offering great convenience. Nevertheless, additional research employing rigorous methodology is required to fine-tune the model. National SCD program may adopt this model, specifically for community-level screening and management of SCD in remote and rural areas.
... The details of these study districts are available elsewhere. 9 The study followed qualitative research principles, employing the Developmental Research Sequence Method developed by James Spradley. 10 An in-depth interview method was used in this qualitative study. ...
Article
Full-text available
Newborn bloodspot screening (NBS) began in the early 1960s based on the work of Dr. Robert “Bob” Guthrie in Buffalo, NY, USA. His development of a screening test for phenylketonuria on blood absorbed onto a special filter paper and transported to a remote testing laboratory began it all. Expansion of NBS to large numbers of asymptomatic congenital conditions flourishes in many settings while it has not yet been realized in others. The need for NBS as an efficient and effective public health prevention strategy that contributes to lowered morbidity and mortality wherever it is sustained is well known in the medical field but not necessarily by political policy makers. Acknowledging the value of national NBS reports published in 2007, the authors collaborated to create a worldwide NBS update in 2015. In a continuing attempt to review the progress of NBS globally, and to move towards a more harmonized and equitable screening system, we have updated our 2015 report with information available at the beginning of 2024. Reports on sub-Saharan Africa and the Caribbean, missing in 2015, have been included. Tables popular in the previous report have been updated with an eye towards harmonized comparisons. To emphasize areas needing attention globally, we have used regional tables containing similar listings of conditions screened, numbers of screening laboratories, and time at which specimen collection is recommended. Discussions are limited to bloodspot screening.
Article
Full-text available
Sickle cell disease (SCD) is a progressively debilitating genetic disease, and India is the second most affected nation in the prevalence of births with SCD. This SCD prevalence is high among Indian indigenous tribal communities, whose healthcare is pluralistic. Traditional healers are an essential part of tribal pluralistic care. This study aimed to understand the extent of SCD-related knowledge and practices of traditional healers and their willingness to participate in the SCD programme, which is primarily meant to screen and treat SCD. Following the grounded theory approach, data were collected by in-depth interviews with 40 traditional healers selected from five SCD endemic districts. Text data were coded through a deductive approach, and thematic content analysis was carried out. A few healers knew about SCD. However, almost all are aware of anaemia and its symptoms. Most healers were unaware of the cause of SCD and mentioned that malnutrition and anaemia are reasons for the recurrence of SCD-related symptoms. Most of the traditional healers did not give any treatment. Some gave symptomatic treatment and provided herbal medicines along with some rituals. Though some healers treated some of the typical symptoms of SCD like spleen enlargement, jaundice, swelling and pains in joints, they did not link them with SCD. All traditional healers expressed concern and said they support the government-run SCD programme. The programme should recognise the role and importance of traditional healers. Necessary education on SCD may be given to the healers. Such involvement and education empower the healers in appropriately guiding the people concerning SCD care.